openPR Logo
Press release

New Report Examines the Febrile Neutropenia Market Research

01-06-2018 01:30 PM CET | Health & Medicine

Press release from: Transparency Market Research

New Report Examines the Febrile Neutropenia Market Research

Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally, patient with febrile neutropenia is treated with prophylactic antibiotics to recover from persistent or recurrent fever conditions.

The market of febrile neutropenia is majorly driven by the efforts of key players to develop novel and cost effective therapeutics. For example, in July 2014, Taiho Pharmaceutical Co., Ltd. filled an application for approval of ZOSYN 2.25 and ZOSYN 4.5 (generic name- tazobactam piperacillin) for additional indication of febrile neutropenia. This product is a combination of antibacterial β-lactamase inhibitor and can be used intravenously. Moreover, in April 2014, Amgen, Inc. collaborated with ONS Edge, Inc. to help educate nurses regarding the patients who are at the risk of febrile neutropenia.

Obtain Report Details @ https://www.transparencymarketresearch.com/febrile-neutropenia-market.html

Thus, these types of efforts will build healthy platform to develop the market of febrile neutropenia hence stimulates the market growth. Additionally, large number of therapeutics under clinical pipelines by key companies will further stimulate the market growth in near future. Positive initiatives by North American and European governments will further drive the market growth of febrile neutropenia.

For example, in September 2013, U.S. Food Drug and Administration (U.S. FDA) approved phase III study of Neulasta (pegfilgrastim) by Amgen, Inc. This study demonstrates increase of white blood cells in patients who are undergoing myelo-suppressive chemotherapy. In addition, in June 2010, Nivestim (TM), a new biosimilar filgrastim by Hospira, Inc. is approved by European Commission. This drug is mainly used for the prevention of febrile neutropenia and offers cost-effective treatment option for neutropenia.

However, lack of specific treatment that enables to treat all the symptoms of this disorder may restrain the growth of this market. In addition, high generic competition among the key players leads to price erosion and ultimately restrains the overall growth of febrile neutropenia market.

Geographically, North America dominates the global febrile neutropenia market. High degree of therapeutic needs for febrile neutropenia coupled with presence of large number of key players like Amgen, Inc., Aequus BioPharma, Inc. and others in North American market will drive the growth of the market. Europe is considered as the second largest market of febrile neutropenia. Large pool of patients under the diagnosis of this disease coupled with increasing demand of treatment fuels the growth of febrile neutropenia market.

In addition, Asia-Pacific region is considered as an emerging market for febrile neutropenia due to the launch of novel drugs with improved efficacy by key companies. In addition, growing awareness for this disorder among the people will further stimulate the growth of febrile neutropenia market in Asia-Pacific region.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2857

Some of the key players in the febrile neutropenia market include Xenetic Biosciences plc, Richter Gedeon Nyrt., Amgen, Inc., Hospira, Inc., Eli Lilly and Company, USV Limited, Aequus BioPharma, Inc., Taiho Pharmaceutical Co., Ltd. and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Report Examines the Febrile Neutropenia Market Research here

News-ID: 888309 • Views: 186

More Releases from Transparency Market Research

Construction Sealants Market Popular Trends & Technological Advancements 2016 …
Overview TMR’s report on the Construction Sealants Market is an all-important tool for Market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Construction Sealants Market serves as a valuable guide for Market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Construction Sealants Market over the
Ceramic Textiles Market Industrial Forecast On Global Industry Analysis & Trends …
Overview TMR’s report on the Ceramic Textiles Market is an all-important tool for Market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Ceramic Textiles Market serves as a valuable guide for Market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Ceramic Textiles Market over the
Automotive Cooling Fan Market : Industry Shares Report Analysis 2018 – 2026
TMR’s report offers a complete analysis of the global Automotive Cooling Fan Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Automotive Cooling Fan Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Report Details: https://www.transparencymarketresearch.com/automotive-cooling-fans-market.html The global Automotive Cooling Fan Market is
Bonding Adhesives Market Analysis & Highly Profitable Investment Decision
Overview TMR’s report on the Bonding Adhesives Market is an all-important tool for Market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Bonding Adhesives Market serves as a valuable guide for Market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Bonding Adhesives Market over the

All 5 Releases


More Releases for Febrile

Febrile Neutropenia Market Forecast, Overview and Cost Structure Analysis to 202 …
The Febrile Neutropenia Market report offers a deep analysis of the Febrile Neutropenia trade. It demonstrates a quick outline of trade knowledge and key Information like Key Manufacturers , Types, Application, Table Of Content, etc of the market. The report highlights Top Venders from the worldwide and Febrile Neutropenia Market along with their worth of the Industry to see their progress. The worldwide Febrile Neutropenia analysis report covers recent enhancements
Febrile Neutropenia Market : Growth Opportunities & Technology Developments by 2 …
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,
Febrile Neutropenia Market Current Trends and Future Aspect Analysis 2020
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,
febrile seizures market is expected to grow at a CAGR 5.5% during the forecast p …
Market Research Future has a half cooked research report on the febrile seizure market. Market Highlights A Febrile Seizure is also known as a fever fit or febrile convulsion, characterized by high body temperature. The condition is most common in children between the ages of 6 months and 5 years. Febrile seizures occur in 2%-4% of children younger than five years old. A number of factor such as growing public awareness, technological advancements,
Global Febrile Seizures Market – Simple and Complex Types, Major Diagnosis, An …
It is estimated that the febrile seizures market is expected to grow at a CAGR 5.5% during the forecast period of 2017-2023. A febrile seizure is one of the most common neurological disorders observed in the pediatric age group. According to the International League against Epilepsy (ILAE), febrile seizure, in childhood, occur as a seizure event featured with temperature over 38°C without any evidence of electrolyte imbalances in CNS infection
Febrile Neutropenia Market To Make Great Impact In Near Future by 2020
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,